ShivkumarShivappaHattiMD

Clinical Trials

• Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01

  Completed

  Phase 2

• Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01

  Completed

• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• Major Depressive Disorder With Mixed Features Start of enrollment: 2012 Jan 01

  Withdrawn

  Phase 3

• Major Depressive Disorder With Mixed Features - Extension Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Start of enrollment: 2014 Jan 01

  Completed

  Phase 2

• Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30

  Completed

  Phase 3

• Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01

  Completed

  Phase 3

• Join now to see all